(AVXL) Anavex Life Sciences - Performance 112.6% in 12m
Compare AVXL with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
35.84%
#12 in Group
Rel. Strength
97.62%
#190 in Universe
Total Return 12m
112.63%
#4 in Group
Total Return 5y
120.59%
#12 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -5.30%
(?) Percentile in Group
12m Total Return: AVXL (112.6%) vs XBI (-14%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
2.95% | 13.3% | 161% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
| HLN NYSE Haleon |
12.6% | 32.2% | 49.3% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
| AMGN NASDAQ Amgen |
-8.67% | -12.4% | 27.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
| LONN SW Lonza |
15.8% | 12% | 33.5% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
| BIM PA Biomerieux |
4.68% | 18.2% | -1.63% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
14.1% | 27.3% | -5.64% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
21.4% | -17.2% | 1.88% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
| ERF PA Eurofins Scientific SE |
22.4% | 0.59% | 8.05% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: AVXL vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for AVXL
| Total Return (including Dividends) | AVXL | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -5.39% | 2.02% | 2.87% |
| 3 Months | -6.36% | -15.44% | -6.42% |
| 12 Months | 112.63% | -14.02% | 9.87% |
| 5 Years | 120.59% | -26.47% | 107.51% |
| Trend Score (consistency of price movement) | AVXL | XBI | S&P 500 |
| 1 Month | -7.90% | 57% | 89.4% |
| 3 Months | 29.1% | -82.3% | -72% |
| 12 Months | 81.7% | -53.1% | 49.3% |
| 5 Years | -17.9% | -53.9% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #86 | -7.26% | -8.03% |
| 3 Month | #37 | 10.7% | 0.06% |
| 12 Month | #4 | 147% | 93.5% |
| 5 Years | #11 | 200% | 6.30% |
FAQs
Does AVXL Anavex Life Sciences outperforms the market?
Yes,
over the last 12 months AVXL made 112.63%, while its related Sector, the SPDR S&P Biotech (XBI) made -14.02%.
Over the last 3 months AVXL made -6.36%, while XBI made -15.44%.
Over the last 3 months AVXL made -6.36%, while XBI made -15.44%.
Performance Comparison AVXL vs Indeces and Sectors
AVXL vs. Indices AVXL is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -11.4% | -8.26% | -4.69% | 103% |
| US NASDAQ 100 | QQQ | -11.7% | -10.1% | -5.10% | 101% |
| US Dow Jones Industrial 30 | DIA | -11.7% | -7.0% | -3.66% | 106% |
| German DAX 40 | DAX | -13.6% | -24.7% | -30.3% | 87.6% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -12.1% | -11.7% | -3.92% | 107% |
| Hongkong Hang Seng | HSI | -15.0% | -21.6% | -14.2% | 101% |
| India NIFTY 50 | INDA | -9.04% | -7.67% | -6.59% | 110% |
| Brasil Bovespa | EWZ | -13.5% | -16.9% | -13.9% | 119% |
AVXL vs. Sectors AVXL is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -11.6% | -9.06% | -10.9% | 92.3% |
| Consumer Discretionary | XLY | -12.4% | -8.90% | -2.50% | 98.6% |
| Consumer Staples | XLP | -11.1% | -7.41% | -11.6% | 105% |
| Energy | XLE | -12.4% | -5.47% | 1.31% | 122% |
| Financial | XLF | -12.1% | -11.0% | -10.6% | 91.1% |
| Health Care | XLV | -7.64% | -1.01% | 0.54% | 119% |
| Industrial | XLI | -13.0% | -12.8% | -5.67% | 103% |
| Materials | XLB | -11.4% | -10.1% | -0.64% | 119% |
| Real Estate | XLRE | -11.1% | -11.5% | -7.07% | 99.2% |
| Technology | XLK | -12.3% | -12.1% | -2.42% | 106% |
| Utilities | XLU | -12.5% | -11.0% | -12.5% | 96.7% |
| Aerospace & Defense | XAR | -11.9% | -14.7% | -14.0% | 87.5% |
| Biotech | XBI | -3.35% | -7.41% | 16.4% | 127% |
| Homebuilder | XHB | -11.0% | -8.46% | 8.94% | 122% |
| Retail | XRT | -11.6% | -8.98% | 1.60% | 117% |